Next Article in Journal
Editorial of Special Issue “Multiple Sclerosis: From Diagnostic Biomarkers to Imaging and Clinical Predictors”
Next Article in Special Issue
Common and Uncommon Errors in Emergency Ultrasound
Previous Article in Journal
Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis
Previous Article in Special Issue
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Early Diagnosis of Acute Myocarditis in the ED: Proposal of a New ECG-Based Protocol

1
Emergency Department, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy
2
Scuola di Specializzazione in Medicina d’Emergenza e Urgenza, Università Degli Studi di Milano, 20122 Milan, Italy
3
Pediatric and Adult Congenital Heart Centre, IRCCS-Policlinico San Donato, 20097 San Donato Milanese, Italy
*
Author to whom correspondence should be addressed.
Diagnostics 2022, 12(2), 481; https://doi.org/10.3390/diagnostics12020481
Submission received: 4 January 2022 / Revised: 29 January 2022 / Accepted: 11 February 2022 / Published: 13 February 2022

Abstract

:
The diagnosis of acute myocarditis (AM) is based on a multi-parametric assessment including clinical presentation, ECG, imaging and biomarkers. Fragmented QRS (fQRS) might be an additional diagnostic sign in patients with proven AM. The main objective of this study was to assess the diagnostic yield of fQRS in patients with suspected AM presenting to the emergency department (ED). Patients admitted between January 2016 and March 2021 with a proven diagnosis of AM, according to clinical, cardiac magnetic resonance (CMR) and/or histologic criteria, were included in the analysis. In total, 51 patients were analyzed (41 men, 78%), with a median age of 36 (29–45) years. Thirty-three (65%) patients had prodromal flu-like symptoms. Patients presented to the ED mostly complaining of chest pain (68%) and palpitations (21%). Seven (14%) patients experienced cardiac arrest, one of whom died. At presentation, 40 patients (78%) displayed fQRS, and 10 (20%) presented ventricular arrhythmias. All the surviving patients underwent CMR and displayed late gadolinium enhancement (LGE). ECG leads showed that fQRS matched the LGE distribution in 38 patients (95%). The presence of fQRS is a simple clinical bedside tool to support the initial suspect of AM in the emergency department and to guide the most appropriate clinical workup.

1. Introduction

Myocarditis is an inflammatory cardiac muscular disease with an extremely heterogeneous etiology [1,2]. The causes may be infective (e.g., bacterial or viral) or non-infective (e.g., drugs, physical and biochemical agents, systemic inflammatory diseases, autoimmune causes) [3,4]. Overall, there are various incidence estimations of myocarditis, ranging from 0.02 to 1.5%, based upon autopsy studies [5,6,7]. Despite invasive and non-invasive treatments, a 10% mortality rate at 3-year follow-up still remains [8]. The average age of patients with myocarditis ranges from 20–51 years [6,9], and it is more common in men [10,11,12].
The diagnosis of acute myocarditis (AM) is based on consistent symptoms, electrocardiogram (ECG), cardiac imaging, serum biomarkers indicative of myocardial damage and endomyocardial biopsy (EMB) [1]. EMB represents the diagnostic gold standard, but in the last years, it has been replaced by cardiac magnetic resonance (CMR) in routine clinical practice [13]. Although aspecific, ECG is still the first-line exam performed in the ED for various cardiac conditions, including AM. Indeed, ECG, together with clinical picture and increase in serum biomarkers, usually allows provisional differential diagnosis between suspected AM and other conditions such as acute coronary syndromes [13,14,15].
The fragmentation of QRS (fQRS) is a diagnostic and prognostic index described in different heart diseases sharing common histopathological characteristics, namely, infiltrates and/or myocardial fibrosis [16]. The common diagnostic feature of QRS fragmentation, described in different clinical setting, is the presence of discernible multiple notches in either the R or S component of the QRS [17]. fQRS has been extensively studied in ischemic heart disease, showing a higher sensitivity as compared to Q wave for the detection of myocardial scar. Moreover, evidences in the setting of ischemic cardiomyopathy suggest a significant correlation with ventricular function and association with cardiac events at follow-up [18,19,20].
We have previously described the reproducibility of fragmented QRS as a complementary diagnostic sign in patients with proven AM in adult and pediatric populations [21,22,23]. This observation stemmed from the hypothesis that pathological changes in myocardium of patients with AM might translate into anisotropic conduction expressed as fQRS in one or more leads.
The “early identification” of patients in the Emergency Department (ED) is the most challenging issue related to myocarditis management due to the risk of rapid evolution towards heart failure and life-threatening arrhythmias. Recently, an Italian group proposed a clinical score for a fast evaluation and identification of patients suffering from myocarditis and attending the ED, not including ECG [24].
We sought to investigate the clinical utility of a systematic search for QRS fragmentation at the time of ED presentation to support the diagnosis of acute myocarditis and to guide early management.

2. Materials and Methods

This was a monocentric, retrospective study involving the ED of Papa Giovanni XXIII in Bergamo, Italy, a tertiary hospital with over 90,000 visits/year. Patients admitted between January 2016 and March 2021 with a proven diagnosis of AM, according to clinical, CMR and/or histologic criteria, were retrospectively analyzed. Clinical variables recorded at baseline were: 12-leads ECG, echocardiography and laboratory findings. Hospital records of admitted patients were also retrieved in order to assess the association of initial presence vs. absence of fQRS with the ascertainment of AM diagnosis. As previously published, fQRS was defined as the presence of an additional R wave (R’) or notching in the nadir of the S wave or the presence of >1 R’ in at least 2 contiguous leads [21,22].
According to the institutional protocol, CMR was performed in all patients admitted with the suspect of AM. CMR was considered diagnostic of AM in the presence of Lake Luis criteria [25].
Distribution of late gadolinium enhancement (LGE) was categorized into three patterns according to the myocardial segment involved: antero-septal, infero-lateral and spotted.
EMB was performed in selected patients from the right side of the interventricular septum under fluoroscopic guidance. Selective coronary angiography was routinely performed in patients older than 40 year or in case of ischemic etiology suspect.
Troponin values were standardized as ratio between patient levels and upper limit of the normal range in order to overcome change of reference values over time.

Statistical Analysis

Continuous variables were reported as median and inter-quartile ranges and compared by Wilkinson rank sum test. Normality of continuous variables was assessed by visually inspecting the distribution histograms. Categorical variables were presented as counts and percentages and compared by χ2 or Fisher exact test.
A p value of 0.05 was assumed as cut-off for statistical significance.
Analysis was performed with STATA 11.0 by Stata Corp.

3. Results

3.1. Clinical Presentation and In-Hospital Course

In total, 51 patients were analyzed (41 men, 78%), 42 (82%) with Caucasian ethnicity and with a median age of 36 (29–45) years. All patients reported prodromal symptoms: 33 (65%) patients had flu-like syndrome symptoms, 16 (31%) had pharyngodinia and 8 (16%) had gastrointestinal syndrome. The symptoms at ED presentation were chest pain (68%), palpitations (21%) and syncope (8%). Seven (14%) patients experienced cardiac arrest, one of whom died. (Table 1)

3.2. Diagnostic Findings and In-Hospital Course

Forty-five (88%) patients had C reactive protein (CRP) elevation, and all patients had elevated Troponin levels. The median CRP was 4.4 (2.5–13.2) mg/dL (n.v. < 1 mg/dL). The highly sensitive Troponin I ratio peak was 176.8 (13.2–438.7) (Table 2). The median ratio of Troponin was not significantly different in patients displaying fQRS, 38 (6.27–116) vs. 20.6 (3.3–52.8) p = 0.24.
The median ejection fraction (EF) was 55% (45–60); 23 patients (45%) had wall motion abnormalities and 9 (18%) had pericardial effusion. All 50 surviving patients underwent CMR during the acute phase (<21 days from admission). Moreover, 11 (22%) patients showed anterior/septal LGE, 21 (42%) patients showed inferior/lateral LGE and 18 (36%) showed spot LGE. Ischemic heart disease was excluded by coronary angiography in 25 (49%) patients. Biopsy was performed in 6 (12%) patients (Table 2).
A total of 35 (68%) patients were admitted to an intensive care unit (ICU), while the 16 (32%) remaining patients were admitted to a cardiology ward. Eight (15%) patients presented with cardiogenic shock or low cardiac output syndrome and needed an inotropic support early during the hospitalization. This latter group included seven (14%) patients who underwent extracorporeal membrane oxygenator (ECMO) (Table 1).

3.3. ECG and QRS Fragmentation

At presentation, ECG was abnormal in 48 (94%) patients. Of these, 19 (37%) ECGs displayed aspecific findings, 23 (45%) showed ST elevation and 7 (14%) showed ST depression. fQRS was visible in 40 (78%) patients. Ventricular arrhythmias occurred in 10 (20%) patients, non-sustained ventricular tachycardia (NSVT) and frequent premature contractions (PVC) occurred in 7 (14%) patients and supra-ventricular arrhythmia occurred in 2 (4%). Two (4%) patients showed first-degree atrio-ventricular block and fourteen (27%) a left or right bundle block. In eight (16%) patients, a device implantation was necessary during the hospitalization or follow-up.
There was a trend towards a higher incidence of ventricular arrhythmias in patients with fQRS (25% vs. 10%, p = 0.2).
Evidence of QRS fragmentation occurred with a latency of 3 (2–6) days from the onset of symptoms. ECG leads showed that fQRS matched the myocardial area of the LGE distribution in 38 patients (95%) (Table 3).
Overall fQRS was identified in 40 out of 50 patients, with CMR-documented acute myocarditis accounting for a sensitivity of 78%.

4. Discussion

Acute myocarditis may present with a wide clinical spectrum, ranging from mild aspecific symptoms to cardiogenic shock and sudden death [26,27,28]. However, an early high-degree of suspicion is of paramount importance, as patients’ conditions can deteriorate very quickly. Diagnosis in the ED is particularly challenging as common diagnostic tools used in the acute setting, and ECG in particular, are commonly believed to be aspecific.
The belief in the lack of specificity of the ECG has been recently challenged by recent data suggesting that fQRS might be a new additional specific sign correlating with the presence and topographic distribution of myocardial inflammation (Figure 1) [21,22].
In this study, we observed that systematic search of fQRS in the first ECG recorded in the ED may be useful for the early triage of patients with suspected myocarditis (Figure 2).
It has previously shown that the presence of QRS fragmentation is associated with evidence of LGE at CMR and impairment of contractility [29,30]. Based on this background, we can hypothesize that the early recognition of myocardial inflammation indicated by presence and extension of fQRS might identify a subset of higher-risk patients, which may deserve early specific work-up (Figure 2). In our cohort, fQRS initially correctly classified 40 out of 51 patients in which acute myocarditis was eventually ascertained. Interestingly, QRS fragmentation appeared with a latency of a few days after symptoms onset. This is consistent with the time elapsed before a critical threshold of inflammation is reached in order to be detected on surface ECG.
We can also speculate that the presence of fQRS, being associated with the extension of inflammation and scar, may be considered a marker of arrhythmic risk, prompting ECG monitoring during ED observation [31]. Indeed, in our cohort, we observed a tendential association of fQRS with a higher incidence of ventricular tachycardia.
If confirmed on larger samples that this preliminary observation might support the clinical validation of a new triage of patients with suspected myocarditis based on the early specific search for fQRS on the ECG at presentation.

Limitations

This study has several limitations. Firstly, this is a retrospective, single-center study involving a limited sample size. Furthermore, fQRS may be particularly subtle, and some training is needed in order to accurately and reproducibly identify this sign. This may have inflated the sensitivity of fQRS in our cohort. Furthermore, the presence of fQRS was assessed by a single investigator, therefore, we do not have data about inter-observer agreement.
Given the variability of the myocardial inflammation evolution, the sensitivity and specificity of this sign may largely vary according to the time elapsed between symptoms onset and ECG recording.

5. Conclusions

ECG is strongly recommended in patients with suspected AM presenting with typical or atypical chest pain or rhythm disturbances. In addition to common aspecific ECG changes, the presence of fQRS is a simple clinical tool to corroborate the initial suspect of AM in the emergency department and to guide the following clinical workup.

Author Contributions

Conceptualization, P.F.; formal analysis, A.M.; writing—original draft, I.P.; writing—review and editing, R.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was performed in agreement with Declaration of Helsinki guidelines. Ethical review and approval were waived for this study, due to the observational, retrospective nature and non-interventional.

Informed Consent Statement

The database of this study was anonymized. The patients agreed on the possible use of their anonymized data for research purpose.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Caforio, A.L.P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S.B.; Fu, M.; Heliö, T.; Heymans, S.; Jahns, R.; et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013, 34, 2636–2648. [Google Scholar] [CrossRef]
  2. Gottlieb, M.; Bridwell, R.; Petrak, V.; Long, B. Diagnosis and Management of Myocarditis: An Evidence-Based Review for the Emergency Medicine Clinician. J. Emerg. Med. 2021, 61, 222–233. [Google Scholar] [CrossRef] [PubMed]
  3. Ferrero, P.; Piazza, I.; Lorini, L.; Senni, M. Epidemiologic and clinical profiles of bacterial myocarditis. Report of two cases and data from a pooled analysis. Indian Hear. J. 2020, 72, 82–92. [Google Scholar] [CrossRef] [PubMed]
  4. Wasi, F.; Shuter, J. Primary bacterial infection of the myocardium. Front. Biosci. 2003, 8, 228–231. [Google Scholar]
  5. Global Burden of Disease Study. Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2013, 386, 743–800. [Google Scholar]
  6. Kytö, V.; Saraste, A.; Voipio-Pulkki, L.M.; Saukko, P. Incidence of fatal myocarditis: A population-based study in Finland. Am. J. Epidemiol. 2007, 165, 570–574. [Google Scholar] [CrossRef] [Green Version]
  7. Passarino, G.; Burlo, P.; Ciccone, G.; Comino, A.; Cravello, M.; Iannicelli, P.; Mollo, F. Prevalence of myocarditis at autopsy in Turin, Italy. Arch. Pathol. Lab. Med. 1997, 121, 619–622. [Google Scholar]
  8. Aoyama, N.; Izumi, T.; Hiramori, K.; Isobe, M.; Kawana, M.; Hiroe, M.; Hishida, H.; Kitaura, Y.; Imaizumi, T.; Japanese Investigators of Fulminant Myocarditis. National survey of fulminant myocarditis in Japan: Therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ. J. 2002, 66, 133–144. [Google Scholar] [CrossRef] [Green Version]
  9. Fenoglio, J.J., Jr.; Ursell, P.C.; Kellogg, C.F.; Drusin, R.E.; Weiss, M.B. Diagnosis and classification of myocarditis by endomyocardial biopsy. N. Engl. J. Med. 1983, 308, 12–18. [Google Scholar] [CrossRef]
  10. Mason, J.W.; O’Connell, J.B.; Herskowitz, A.; Rose, N.R.; McManus, B.M.; Billingham, M.E.; Moon, T.E. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 1995, 333, 269–275. [Google Scholar] [CrossRef]
  11. Caforio, A.L.P.; Calabrese, F.; Angelini, A.; Tona, F.; Vinci, A.; Bottaro, S.; Ramondo, A.; Carturan, E.; Iliceto, S.; Thiene, G.; et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clin- ical and aetiopathogenetic features at diagnosis. Eur. Heart. J. 2007, 28, 1326–1333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Magnani, J.W.; Danik, H.J.; Dec, G.W., Jr.; Di Salvo, T.G. Survival in biopsy proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 2006, 151, 463–470. [Google Scholar] [CrossRef]
  13. Aquaro, G.D.; Perfetti, M.; Camastra, G.; Monti, L.; Dellegrottaglie, S.; Moro, C.; Pepe, A.; Todiere, G.; Lanzillo, C.; Scatteia, A.; et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY Study. J. Am. Coll. Cardiol. 2017, 70, 1977–1987. [Google Scholar] [CrossRef] [PubMed]
  14. Tschöpe, C.; Cooper, L.T.; Torre-Amione, G.; Van Linthou, S. Management of myocarditis-related cardiomyopathy in adults. Circ. Res. 2019, 124, 1568–1583. [Google Scholar] [CrossRef]
  15. Kindermann, I.; Kindermann, M.; Kandolf, R.; Klingel, K.; Bültmann, B.; Müller, T.; Lindinger, A.; Böhm, M. Predictors of outcome in patients with suspected myocarditis. Circulation 2008, 118, 639–648. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Ukena, C.; Mahfoud, F.; Kindermann, I.; Kandolf, R.; Kindermann, M.; Böhm, M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur. J. Heart Fail 2011, 13, 398–405. [Google Scholar] [CrossRef]
  17. Haukilahti, M.A.; Eranti, A.; Kenttä, T.; Huikuri, H.V. QRS fragmentation patterns representing myocardial scar need to be separated from benign normal variants: Hypotheses and proposal for morphology based classification. Front Physiol. 2016, 7, 653. [Google Scholar] [CrossRef] [Green Version]
  18. Redfors, B.; Kosmidou, I.; Crowley, A.; Maehara, A.; Ben-Yehuda, O.; Arif, A.; Dizon, J.M.; Mintz, G.S.; Stone, G.W. Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial. Int. J. Cardiol. 2018, 253, 20–24. [Google Scholar] [CrossRef]
  19. Jain, R.; Singh, R.; Yamini, S.; Das, M.K. Fragmented ECG as a risk marker in cardiovascular diseases. Curr. Cardiol. Rev. 2014, 10, 277–286. [Google Scholar] [CrossRef] [Green Version]
  20. Das, M.K.; Khan, B.; Jacob, S.; Kumar, A.; Mahenthiran, J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 2006, 113, 2495–2501. [Google Scholar] [CrossRef] [Green Version]
  21. Ferrero, P.; Piazza, I.; Grosu, A.; Brambilla, P.; Sironi, S.; Senni, M. QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance. Eur. J. Heart Fail. 2019, 21, 1160–1161. [Google Scholar] [CrossRef] [PubMed]
  22. Ferrero, P.; Piazza, I.; Kühl, U.; Grosu, A.; Tschöpe, C.; Senni, M. QRS fragmentation as a possible electrocardiographic diagnostic marker in patients with acute myocarditis: Preliminary histopathological validation. ESC Heart Fail. 2020, 7, 2527–2533. [Google Scholar] [CrossRef] [PubMed]
  23. Ferrero, P.; Piazza, I. QRS fragmentation in children with suspected myocarditis: A possible additional diagnostic sign. Cardiol Young. 2020, 30, 962–966. [Google Scholar] [CrossRef]
  24. Scicchitano, P.; Grazioli Gauthier, L.; D’Agostino, C.; Caldarola, P.; Solarino, B.; Massari, F.; Chiarella, F.; Sinagra, G.; Manca, F.; Ciccone, M.M. The Diagnosis of Acute Myocarditis in Emergency (DAME) score: Improving diagnostics within the emergency department. Eur. J. Intern. Med. 2021, 85, 56–62. [Google Scholar] [CrossRef] [PubMed]
  25. Friedrich, M.G.; Sechtem, U.; Schulz-Menger, J.; Holmvang, G.; Alakija, P.; Cooper, L.T.; White, J.A.; Abdel-Aty, H.; Gutberlet, M.; Prasad, S.; et al. Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J. Am. Coll Cardiol. 2009, 53, 1475–1487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Ammirati EFrigerio, M.; Adler, E.D.; Basso, C.; Birnie, D.H.; Brambatti, M.; Friedrich, M.G.; Klingel, K.; Lehtonen, J.; Moslehi, J.J.; Pedrotti, P.; et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ. Heart Fail. 2020, 13, e007405. [Google Scholar]
  27. Imazio, M.; Angelico, G.; Andriani, M.; Lobetti-Bodoni, L.; Davini, O.; Giustetto, C.; Rinaldi, M. Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis with or Without Preserved Left Ventricular Function. Am. J. Cardiol. 2018, 122, 1955–1958. [Google Scholar] [CrossRef] [PubMed]
  28. Peretto, G.; Sala, S.; Rizzo, S.; De Luca, G.; Campochiaro, C.; Sartorelli, S.; Benedetti, G.; Palmisano, A.; Esposito, A.; Tresoldi, M.; et al. Arrhythmias in myocarditis: State of the art. Heart Rhythm. 2019, 16, 793–801. [Google Scholar] [CrossRef]
  29. Konno, T.; Hayashi, K.; Fujino, N.; Oka, R.; Nomura, A.; Nagata, Y.; Hodatsu, A.; Sakata, K.; Furusho, H.; Takamura, M.; et al. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy. J. Cardiovasc. Electrophysiol. 2015, 26, 1081–1087. [Google Scholar] [CrossRef]
  30. Basaran, Y.; Tigen, K.; Karaahmet, T.; Isiklar, I.; Cevik, C.; Gurel, E.; Dundar, C.; Pala, S.; Mahmutyazicioglu, K.; Basaran, O. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography 2011, 28, 62–68. [Google Scholar] [CrossRef]
  31. Peretto, G.; Sala, S.; Rizzo, S.; Palmisano, A.; Esposito, A.; De Cobelli, F.; Campochiaro, C.; De Luca, G.; Foppoli, L.; Dagna, L.; et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships with Myocardial Inflammation. J. Am. Coll. Cardiol. 2020, 75, 1046–1057. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) ECG showing fQRA in leads V1, V2, DIII and aVF; (B) Magnification of fQRS; (C) CMR short-axis view with LGE in inferior-lateral and septal areas.
Figure 1. (A) ECG showing fQRA in leads V1, V2, DIII and aVF; (B) Magnification of fQRS; (C) CMR short-axis view with LGE in inferior-lateral and septal areas.
Diagnostics 12 00481 g001
Figure 2. Algorithm assessment of patient with suspected myocarditis in Emergency Department.
Figure 2. Algorithm assessment of patient with suspected myocarditis in Emergency Department.
Diagnostics 12 00481 g002
Table 1. General demographics and clinical and diagnostic characteristics of the population at presentation at the emergency department. IQR: interquartile range.
Table 1. General demographics and clinical and diagnostic characteristics of the population at presentation at the emergency department. IQR: interquartile range.
n = 51
Age (years), median (IQR)36 (29–45)
Male, n (%)41 (78)
Caucasian ethnicity42 (82)
Prodromal Symptoms, n (%)
Prodromal symptoms duration, median (IQR)3 (2–6.5)
Fever/Flu-like syndrome, n (%)33 (65)
Pharyngeal pain, n (%)16 (31)
Gastrointestinal disorders, n (%)8 (16)
Clinical presentation/In-hospital course
Chest pain, n (%)35 (68)
Palpitations, n (%)11 (21)
Syncope, n (%)4 (8)
Cardiac Arrest, n (%)7 (14)
Inotropic support, n (%)8 (15)
Mechanical respiratory/circulatory support, n (%)7 (14)
Table 2. Diagnostic findings in patients admitted to ED with AMAM: acute myocarditis; CRP: C reactive protein; LVEF: left ventricular ejection fraction; CMR: cardiac magnetic resonance.
Table 2. Diagnostic findings in patients admitted to ED with AMAM: acute myocarditis; CRP: C reactive protein; LVEF: left ventricular ejection fraction; CMR: cardiac magnetic resonance.
n = 51
Laboratory findings at presentation
CRP mg/dL, median (IQR)4.4 (2.5–13.2)
Troponin ratio, median (IQR)176.8 (13.2–438.7)
Echocardiography, n (%)
LVEF (%), median (IQR)55 (45–60)
Wall motion abnormalities, n (%)23 (45)
Pericardial effusion, n (%)9 (18)
Biopsy, n (%)6 (12)
Coronary angiography, n (%)25 (49)
CMR, n (%)n = 50
LVEF (%), median (%)58 (52–61.2)
LGE, n (%)50 (100)
Antero-septal LGE, n (%)11 (22)
Infero-lateral LGE, n (%)21 (42)
Other-pattern LGE, n (%)18 (36)
Table 3. ECG and rhythm disturbance in patients admitted with AM.
Table 3. ECG and rhythm disturbance in patients admitted with AM.
n = 51
ST elevation, n (%)23 (45)
Aspecific abnormalities, n (%)19 (37)
ST depression, n (%)7 (14)
Ventricular Arrhythmia, n (%) 10 (20)
NSVT or frequent PVC, n (%)7 (14)
Supraventricular arrhythmia, n (%)2 (4)
Device implantation, n (%)8 (16)
QRS fragmentation, n (%)40 (78)
Latency of fQRS occurrence (days), median (IQR)3 (2–6)
fQRS matching LGE distribution, n (%)38 (95)
Wall motion anomalies, n (%)23 (45)
Pericardial effusion, n (%)9 (18)
AM: acute myocarditis; NSVT: non sustained ventricular tachicardia; PVC: premature ventricular contractions; fQRS: fragmented QRS; LGE: late gadolinium enhancement.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Piazza, I.; Ferrero, P.; Marra, A.; Cosentini, R. Early Diagnosis of Acute Myocarditis in the ED: Proposal of a New ECG-Based Protocol. Diagnostics 2022, 12, 481. https://doi.org/10.3390/diagnostics12020481

AMA Style

Piazza I, Ferrero P, Marra A, Cosentini R. Early Diagnosis of Acute Myocarditis in the ED: Proposal of a New ECG-Based Protocol. Diagnostics. 2022; 12(2):481. https://doi.org/10.3390/diagnostics12020481

Chicago/Turabian Style

Piazza, Isabelle, Paolo Ferrero, Alessio Marra, and Roberto Cosentini. 2022. "Early Diagnosis of Acute Myocarditis in the ED: Proposal of a New ECG-Based Protocol" Diagnostics 12, no. 2: 481. https://doi.org/10.3390/diagnostics12020481

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop